All Curated Mutation Sites in HIV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All
  
IN
  
RT
  
LTR
  
CA
  
Gag
  
Nef
  
Env
  
gp120
  
gp160
  
gp41
  
gp140
  
MA
  
Pol
  
PR
  
Rev
  
Tat
  
Vpu
  
Vif
  
Vpr
  

Keyword: HIV Infections-40284921
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 40284921 154L
PR
gag-pol
HIV Infections
D
G
C
L
View
2 40284921 154V
PR
gag-pol
HIV Infections
D
G
C
L
View
3 40284921 69insT
RT
gag-pol
HIV Infections
D
G
C
L
View
4 40284921 A128T
IN
gag-pol
HIV Infections
D
G
C
L
View
5 40284921 A62V
RT
gag-pol
HIV Infections
D
G
C
L
View
6 40284921 A98G
RT
gag-pol
HIV Infections
D
G
C
L
View
7 40284921 D30N
PR
gag-pol
HIV Infections
D
G
C
L
View
8 40284921 D67G
RT
gag-pol
HIV Infections
D
G
C
L
View
9 40284921 D67N
RT
gag-pol
HIV Infections
D
G
C
L
View
10 40284921 D67R
RT
gag-pol
HIV Infections
D
G
C
L
View
11 40284921 E138A
RT
gag-pol
HIV Infections
D
G
C
L
View
12 40284921 E138G
RT
gag-pol
HIV Infections
D
G
C
L
View
13 40284921 E138K
RT
gag-pol
HIV Infections
D
G
C
L
View
14 40284921 E138Q
RT
gag-pol
HIV Infections
D
G
C
L
View
15 40284921 E157Q
IN
gag-pol
HIV Infections
D
G
C
L
View
16 40284921 E44D
RT
gag-pol
HIV Infections
D
G
C
L
View
17 40284921 E92G
IN
gag-pol
HIV Infections
D
G
C
L
View
18 40284921 E92Q
IN
gag-pol
HIV Infections
D
G
C
L
View
19 40284921 F53L
PR
gag-pol
HIV Infections
D
G
C
L
View
20 40284921 G140S
IN
gag-pol
HIV Infections
D
G
C
L
View
21 40284921 G163K
IN
gag-pol
HIV Infections
D
G
C
L
View
22 40284921 G163R
IN
gag-pol
HIV Infections
D
G
C
L
View
23 40284921 G190S
RT
gag-pol
HIV Infections
D
G
C
L
View
24 40284921 I50L
PR
gag-pol
HIV Infections
D
G
C
L
View
25 40284921 I50V
PR
gag-pol
HIV Infections
D
G
C
L
View
26 40284921 I84V
PR
gag-pol
HIV Infections
D
G
C
L
View
27 40284921 K101E
RT
gag-pol
HIV Infections
D
G
C
L
View
28 40284921 K101Q
RT
gag-pol
HIV Infections
D
G
C
L
View
29 40284921 K101R
RT
gag-pol
HIV Infections
D
G
C
L
View
30 40284921 K103E
RT
gag-pol
HIV Infections
D
G
C
L
View
31 40284921 K103N
RT
gag-pol
HIV Infections
D
G
C
L
View
32 40284921 K103R
RT
gag-pol
HIV Infections
D
G
C
L
View
33 40284921 K20T
PR
gag-pol
HIV Infections
D
G
C
L
View
34 40284921 K219Q
RT
gag-pol
HIV Infections
D
G
C
L
View
35 40284921 K219R
RT
gag-pol
HIV Infections
D
G
C
L
View
36 40284921 K43T
PR
gag-pol
HIV Infections
D
G
C
L
View
37 40284921 K65R
RT
gag-pol
HIV Infections
D
G
C
L
View
38 40284921 K70E
RT
gag-pol
HIV Infections
D
G
C
L
View
39 40284921 K70N
RT
gag-pol
HIV Infections
D
G
C
L
View
40 40284921 K70Q
RT
gag-pol
HIV Infections
D
G
C
L
View
41 40284921 K70R
RT
gag-pol
HIV Infections
D
G
C
L
View
42 40284921 K70T
RT
gag-pol
HIV Infections
D
G
C
L
View
43 40284921 L100V
RT
gag-pol
HIV Infections
D
G
C
L
View
44 40284921 L210W
RT
gag-pol
HIV Infections
D
G
C
L
View
45 40284921 L33F
PR
gag-pol
HIV Infections
D
G
C
L
View
46 40284921 L74I
RT
gag-pol
HIV Infections
D
G
C
L
View
47 40284921 L76V
PR
gag-pol
HIV Infections
D
G
C
L
View
48 40284921 M184I
RT
gag-pol
HIV Infections
D
G
C
L
View
49 40284921 M184V
RT
gag-pol
HIV Infections
D
G
C
L
View
50 40284921 M230I
RT
gag-pol
HIV Infections
D
G
C
L
View
51 40284921 M41L
RT
gag-pol
HIV Infections
D
G
C
L
View
52 40284921 M46I
PR
gag-pol
HIV Infections
D
G
C
L
View
53 40284921 M46L
PR
gag-pol
HIV Infections
D
G
C
L
View
54 40284921 N155H
IN
gag-pol
HIV Infections
D
G
C
L
View
55 40284921 N155T
IN
gag-pol
HIV Infections
D
G
C
L
View
56 40284921 N348I
RT
gag-pol
HIV Infections
D
G
C
L
View
57 40284921 N63D
PR
gag-pol
HIV Infections
D
G
C
L
View
58 40284921 Q148H
IN
gag-pol
HIV Infections
D
G
C
L
View
59 40284921 Q148R
IN
gag-pol
HIV Infections
D
G
C
L
View
60 40284921 Q58E
PR
gag-pol
HIV Infections
D
G
C
L
View
61 40284921 Q95K
IN
gag-pol
HIV Infections
D
G
C
L
View
62 40284921 R263K
IN
gag-pol
HIV Infections
D
G
C
L
View
63 40284921 S147G
IN
gag-pol
HIV Infections
D
G
C
L
View
64 40284921 S230R
IN
gag-pol
HIV Infections
D
G
C
L
View
65 40284921 T215C
RT
gag-pol
HIV Infections
D
G
C
L
View
66 40284921 T215D
RT
gag-pol
HIV Infections
D
G
C
L
View
67 40284921 T215E
RT
gag-pol
HIV Infections
D
G
C
L
View
68 40284921 T215I
RT
gag-pol
HIV Infections
D
G
C
L
View
69 40284921 T215S
RT
gag-pol
HIV Infections
D
G
C
L
View
70 40284921 T215Y
RT
gag-pol
HIV Infections
D
G
C
L
View
71 40284921 T66A
IN
gag-pol
HIV Infections
D
G
C
L
View
72 40284921 T69D
RT
gag-pol
HIV Infections
D
G
C
L
View
73 40284921 T97A
IN
gag-pol
HIV Infections
D
G
C
L
View
74 40284921 V108I
RT
gag-pol
HIV Infections
D
G
C
L
View
75 40284921 V179D
RT
gag-pol
HIV Infections
D
G
C
L
View
76 40284921 V179E
RT
gag-pol
HIV Infections
D
G
C
L
View
77 40284921 V179T
RT
gag-pol
HIV Infections
D
G
C
L
View
78 40284921 V75A
RT
gag-pol
HIV Infections
D
G
C
L
View
79 40284921 V75M
RT
gag-pol
HIV Infections
D
G
C
L
View
80 40284921 V82A
PR
gag-pol
HIV Infections
D
G
C
L
View
81 40284921 Y115F
RT
gag-pol
HIV Infections
D
G
C
L
View
82 40284921 Y143C
IN
gag-pol
HIV Infections
D
G
C
L
View
83 40284921 Y143R
IN
gag-pol
HIV Infections
D
G
C
L
View
84 40284921 Y188C
RT
gag-pol
HIV Infections
D
G
C
L
View
85 40284921 Y188L
RT
gag-pol
HIV Infections
D
G
C
L
View
86 40284921 Y318F
RT
gag-pol
HIV Infections
D
G
C
L
View
Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.